Fate Therapeutics Inc (NASDAQ:FATE)

12.89
BATS BZX Real-Time Price
As of 2:49pm ET
 +0.30 / +2.38%
Today’s Change
3.80
Today|||52-Week Range
16.94
+110.97%
Year-to-Date
No recent news for Fate Therapeutics Inc.

Today’s Trading

Previous close12.59
Today’s open12.50
Day’s range12.36 - 12.91
Volume9,473
Average volume (3 months)622,286
Market cap$812.3M
Data as of 2:49pm ET, 11/16/2018

Growth & Valuation

Earnings growth (last year)+2.86%
Earnings growth (this year)-16.60%
Earnings growth (next 5 years)--
Revenue growth (last year)-6.72%
P/E ratioNM
Price/Sales62.47
Price/Book8.59

Competitors

 Today’s
change
Today’s
% change
IMGNImmunoGen Inc+0.14+2.40%
DCPHDeciphera Pharmaceut...-0.41-1.80%
QUREUniqure NV+0.93+3.01%
NTLAIntellia Therapeutic...+0.27+1.56%
Data as of 2:50pm ET, 11/16/2018

Financials

Next reporting dateMarch 14, 2019
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$4.1M
Annual profit (last year)-$43.0M
Net profit margin-1,046.08%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
J. Scott Wolchko
Chief Scientific Officer
Daniel D. Shoemaker
Corporate headquarters
San Diego, California

Forecasts